Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

Natural killer (NK) cells are what they sound like – naturally ... not too dissimilar to other approaches to treat cancer using cell therapy. “The results of this POC study highlight the ...

HOUSTON, March 13, 2025 /PRNewswire/ -- PranaX Corporation (www.pranax.com), an emerging regenerative medicine biotechnology company, today announced that it has licensed exosome technology from ...

While the trial focuses on stem cell transplantation, it hints at broader mechanisms—like exosome release—that could transform Parkinson's care by repairing brain damage and enhancing dopamine ...

The company's first commercial product, ExoWELLTM, is a physician-directed, GMP stem cell exosome supplement for application in health and wellness. It has the potential to modulate cellular ...